rs137852211
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_194277.3(FRMD7):āc.425T>Gā(p.Leu142Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000917 in 1,090,293 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_194277.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMD7 | NM_194277.3 | c.425T>G | p.Leu142Arg | missense_variant | 6/12 | ENST00000298542.9 | NP_919253.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMD7 | ENST00000298542.9 | c.425T>G | p.Leu142Arg | missense_variant | 6/12 | 1 | NM_194277.3 | ENSP00000298542 | P1 | |
FRMD7 | ENST00000464296.1 | c.380T>G | p.Leu127Arg | missense_variant | 6/12 | 1 | ENSP00000417996 | |||
FRMD7 | ENST00000370879.5 | c.65T>G | p.Leu22Arg | missense_variant | 2/8 | 1 | ENSP00000359916 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183350Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67832
GnomAD4 exome AF: 9.17e-7 AC: 1AN: 1090293Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 355913
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Nystagmus 1, congenital, X-linked Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 29, 2007 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Clinical Genomics Laboratory, Washington University in St. Louis | Aug 02, 2023 | The FRMD7 c.425T>G (p.Leu142Arg) variant has been reported in three unrelated families affected with nystagmus, and is reported to segregate with disease in two of these families (Tarpey P et al., PMID: 17013395; Shiels A et al., PMID: 18087240). This variant is only observed on 1/183,350 alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. Computational predictors suggest that the variant is damaging, evidence that correlates with impact to FRMD7 function. This variant has been submitted to ClinVar as pathogenic by one laboratory (Variation ID: 10788). Based on available information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as likely pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 09, 2023 | This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 142 of the FRMD7 protein (p.Leu142Arg). This variant is present in population databases (rs137852211, gnomAD 0.001%). This missense change has been observed in individual(s) with X-linked congenital nystagmus (PMID: 17013395, 18087240). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10788). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21904664, 18087240, 17013395) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at